Skip to main content
. 2021 Aug 27;13(9):1344. doi: 10.3390/pharmaceutics13091344

Figure 5.

Figure 5

Schematic illustration of the delivery of immunotherapeutic agents through BP nanomaterials in cancer immunotherapy. The checkpoint inhibitor, antigen, and immunoadjuvant are three main types of immunotherapeutic agents which can be loaded on BP nanomaterials to elicit distinct effects for cancer immunotherapy.